About
AxioTechBio is a pan-European market access and commercial representation company for life sciences, with sites in Paris, Barcelona and Copenhagen. We don't just plan exploitation — we take results to market in France and Spain.
Track record: our founder brings nearly 20 years of commercial leadership in clinical genomics and life sciences. In 2026, AxioTechBio has worked on public tenders for research and healthcare institutions in Spain and France, and represents several European omics and diagnostics companies.
In Horizon Europe consortia, AxioTechBio contributes to exploitation and industry uptake through its Market & Procurement Readiness Kit:
– Exploitable results map and market sizing for France and Spain
– End-user needs and value proposition with hospital laboratories and clinicians
– Public procurement map: buyers, procurement procedures, tender calendars and award criteria
– Go-to-market, adoption and sustainability plan
– Industry-facing dissemination
After the project, AxioTechBio can commercially represent the consortium's exploitable results in France and Spain, giving the proposal a concrete route to market.
We also bridge academia and industry: through our network of European omics and diagnostics SMEs (miRNA biomarkers, single-cell and spatial genomics, metabolomics/lipidomics, clinical bioinformatics, sequencing services), we help coordinators identify and onboard suitable SME partners. Regulatory (IVDR/MDR) and HTA work is delivered with specialised partners.